{"ticker": "AKER", "overview": {"cik": "1321834", "ticker": "QCLS", "name": "Q/C TECHNOLOGIES, INC.", "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "sic": "2835", "announcements": [{"form": "4", "date": "2026-10-02", "title": "Insider transaction", "accession": "0001493152-26-045586", "price_sensitive": false}, {"form": "4/A", "date": "2026-10-02", "title": "Form 4/A", "accession": "0001493152-26-045576", "price_sensitive": false}, {"form": "3", "date": "2026-09-22", "title": "Initial insider holdings", "accession": "0001493152-26-043729", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-18", "title": "Material event", "accession": "0001493152-26-043401", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-11", "title": "Material event", "accession": "0001493152-26-042394", "price_sensitive": true}, {"form": "3", "date": "2026-08-17", "title": "Initial insider holdings", "accession": "0001493152-26-038855", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-12", "title": "Quarterly report", "accession": "0001493152-26-037333", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001493152-26-031946", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023751", "price_sensitive": true}, {"form": "4", "date": "2026-05-14", "title": "Insider transaction", "accession": "0001493152-26-023217", "price_sensitive": false}, {"form": "10-K/A", "date": "2026-04-29", "title": "Form 10-K/A", "accession": "0001493152-26-019663", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016913", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016910", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016914", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016911", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016912", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016909", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016872", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-03-31", "title": "Form NT 10-K", "accession": "0001493152-26-014222", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010070", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-02-17", "title": "Form EFFECT", "accession": "9999999995-26-000618", "price_sensitive": false}, {"form": "CORRESP", "date": "2026-02-12", "title": "Form CORRESP", "accession": "0001493152-26-006490", "price_sensitive": false}, {"form": "S-3", "date": "2026-02-11", "title": "Shelf registration", "accession": "0001493152-26-006234", "price_sensitive": false}, {"form": "4", "date": "2026-01-30", "title": "Insider transaction", "accession": "0001493152-26-004565", "price_sensitive": false}, {"form": "3", "date": "2026-01-30", "title": "Initial insider holdings", "accession": "0001493152-26-004564", "price_sensitive": false}]}, "description": "AKER trades as AKER. Privy Trades holds 44 insider filings for the company, from August 2014 to February 2020. Across those, 4 insiders disclosed 5 open-market purchases totalling $572.39K against 2 sales totalling $81.37K. The most recent filing on record is dated 11 September 2020.", "exchange": null, "stats": {"buy_n": 5, "buy_sum": 572394.29, "sell_n": 2, "sell_sum": 81368.78, "net": 491025.51, "insiders": 4, "first_date": "2014-08-22", "last_date": "2020-02-28"}, "metrics": {"ticker": "AKER", "has_prices": false}, "trades": [{"id": "0001493152-20-017668", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Exec. Chairman and President, Director", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "President files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220017668/0001493152-20-017668-index.htm", "trade_date": "2020-09-11", "timestamp": "2020-09-11", "mins": 3230872}, {"id": "0001493152-20-017670", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Robert C. Schroeder", "who_key": "SCHROEDER ROBERT C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220017670/0001493152-20-017670-index.htm", "trade_date": "2020-09-11", "timestamp": "2020-09-11", "mins": 3230872}, {"id": "0001493152-20-017672", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220017672/0001493152-20-017672-index.htm", "trade_date": "2020-09-11", "timestamp": "2020-09-11", "mins": 3230872}, {"id": "0001493152-20-017674", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220017674/0001493152-20-017674-index.htm", "trade_date": "2020-09-11", "timestamp": "2020-09-11", "mins": 3230872}, {"id": "0001393825-20-000097", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Hudson Bay Capital Management LP", "who_key": "Hudson Bay Capital Management LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "SELL", "amount": 1792.78, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "The whale sells $2K of AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000097/0001393825-20-000097-index.htm", "trade_date": "2020-02-28", "timestamp": "2020-02-28", "mins": 3513112}, {"id": "0001393825-20-000096", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Hudson Bay Capital Management LP", "who_key": "Hudson Bay Capital Management LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "SELL", "amount": 79576.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "The whale sells $80K of AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000096/0001393825-20-000096-index.htm", "trade_date": "2020-02-27", "timestamp": "2020-02-27", "mins": 3514552}, {"id": "0001493152-20-000164", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220000164/0001493152-20-000164-index.htm", "trade_date": "2020-01-01", "timestamp": "2020-01-01", "mins": 3596632}, {"id": "0001493152-20-000165", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220000165/0001493152-20-000165-index.htm", "trade_date": "2020-01-01", "timestamp": "2020-01-01", "mins": 3596632}, {"id": "0001493152-20-000166", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Executive Chairman, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315220000166/0001493152-20-000166-index.htm", "trade_date": "2020-01-01", "timestamp": "2020-01-01", "mins": 3596632}, {"id": "0001393825-20-000002", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Hudson Bay Capital Management LP", "who_key": "Hudson Bay Capital Management LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 555550.43, "score": 52.7, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Major holder piles $556K into AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000002/0001393825-20-000002-index.htm", "trade_date": "2019-12-20", "timestamp": "2019-12-20", "mins": 3613912}, {"id": "0001493152-19-014946", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1560.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219014946/0001493152-19-014946-index.htm", "trade_date": "2019-10-02", "timestamp": "2019-10-02", "mins": 3727672}, {"id": "0001493152-19-013695", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1612.5, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219013695/0001493152-19-013695-index.htm", "trade_date": "2019-08-30", "timestamp": "2019-08-30", "mins": 3775192}, {"id": "0001493152-19-011469", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1575.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219011469/0001493152-19-011469-index.htm", "trade_date": "2019-07-31", "timestamp": "2019-07-31", "mins": 3818392}, {"id": "0001493152-19-009915", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 1695.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219009915/0001493152-19-009915-index.htm", "trade_date": "2019-06-28", "timestamp": "2019-06-28", "mins": 3865912}, {"id": "0001493152-19-008425", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 4875.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219008425/0001493152-19-008425-index.htm", "trade_date": "2019-05-24", "timestamp": "2019-05-24", "mins": 3916312}, {"id": "0001493152-19-004303", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 14550.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219004303/0001493152-19-004303-index.htm", "trade_date": "2019-03-29", "timestamp": "2019-03-29", "mins": 3996952}, {"id": "0001493152-19-004746", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Christopher C. Schreiber", "who_key": "Schreiber Christopher C", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219004746/0001493152-19-004746-index.htm", "trade_date": "2019-03-29", "timestamp": "2019-03-29", "mins": 3996952}, {"id": "0001493152-19-004747", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Billy Joe White", "who_key": "White Billy Joe", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219004747/0001493152-19-004747-index.htm", "trade_date": "2019-03-29", "timestamp": "2019-03-29", "mins": 3996952}, {"id": "0001493152-19-004748", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Joshua Silverman", "who_key": "Silverman Joshua", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219004748/0001493152-19-004748-index.htm", "trade_date": "2019-03-29", "timestamp": "2019-03-29", "mins": 3996952}, {"id": "0001493152-19-000042", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Howard Yeaton", "who_key": "Yeaton Howard", "role": "CEO, CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 9525.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315219000042/0001493152-19-000042-index.htm", "trade_date": "2018-12-28", "timestamp": "2018-12-28", "mins": 4127992}, {"id": "0001493152-17-011992", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 132000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315217011992/0001493152-17-011992-index.htm", "trade_date": "2017-10-17", "timestamp": "2017-10-17", "mins": 4757272}, {"id": "0001493152-17-011994", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Gary M. Rauch", "who_key": "RAUCH GARY M", "role": "VP - Finance, Treasurer", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 31923.76, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315217011994/0001493152-17-011994-index.htm", "trade_date": "2017-10-17", "timestamp": "2017-10-17", "mins": 4757272}, {"id": "0001493152-18-005018", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 132000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315218005018/0001493152-18-005018-index.htm", "trade_date": "2017-10-17", "timestamp": "2017-10-17", "mins": 4757272}, {"id": "0001493152-16-010784", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 54725.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216010784/0001493152-16-010784-index.htm", "trade_date": "2016-06-08", "timestamp": "2016-06-08", "mins": 5471512}, {"id": "0001493152-18-005016", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 54725.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "CEO files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315218005016/0001493152-18-005016-index.htm", "trade_date": "2016-06-08", "timestamp": "2016-06-08", "mins": 5471512}, {"id": "0001493152-16-010274", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 5566.86, "score": 49.8, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "AKER catches the CEO's eye: $6K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216010274/0001493152-16-010274-index.htm", "trade_date": "2016-05-24", "timestamp": "2016-05-24", "mins": 5493112}, {"id": "0001493152-16-006629", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Raymond Francis Akers Jr", "who_key": "AKERS RAYMOND FRANCIS JR", "role": "Executive Chairman, Secretary, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 2814.0, "score": 22.4, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "The whole bench is buying AKER \u2014 3 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216006629/0001493152-16-006629-index.htm", "trade_date": "2016-01-05", "timestamp": "2016-01-05", "mins": 5694712}, {"id": "0001493152-15-006483", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Raza Bokhari", "who_key": "Bokhari Raza", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006483/0001493152-15-006483-index.htm", "trade_date": "2015-12-30", "timestamp": "2015-12-30", "mins": 5703352}, {"id": "0001493152-15-006485", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Robert E. Andrews", "who_key": "Andrews Robert E", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Director files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006485/0001493152-15-006485-index.htm", "trade_date": "2015-12-30", "timestamp": "2015-12-30", "mins": 5703352}, {"id": "0001493152-15-006487", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Gary M. Rauch", "who_key": "RAUCH GARY M", "role": "VP - Finance, Treasurer", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Insider files routine paperwork on AKER \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006487/0001493152-15-006487-index.htm", "trade_date": "2015-12-30", "timestamp": "2015-12-30", "mins": 5703352}], "recent_buys": [{"id": "0001393825-20-000002", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences, Inc.", "who": "Hudson Bay Capital Management LP", "who_key": "Hudson Bay Capital Management LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "action": "BUY", "amount": 555550.43, "score": 52.7, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "Major holder piles $556K into AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000002/0001393825-20-000002-index.htm", "trade_date": "2019-12-20", "timestamp": "2019-12-20", "mins": 3613912}, {"id": "0001493152-16-010274", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 5566.86, "score": 49.8, "price_sensitive": true, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "AKER catches the CEO's eye: $6K bought", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216010274/0001493152-16-010274-index.htm", "trade_date": "2016-05-24", "timestamp": "2016-05-24", "mins": 5493112}, {"id": "0001493152-16-006629", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Raymond Francis Akers Jr", "who_key": "AKERS RAYMOND FRANCIS JR", "role": "Executive Chairman, Secretary, Director", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 2814.0, "score": 22.4, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "The whole bench is buying AKER \u2014 3 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216006629/0001493152-16-006629-index.htm", "trade_date": "2016-01-05", "timestamp": "2016-01-05", "mins": 5694712}, {"id": "0001493152-15-006213", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Gary M. Rauch", "who_key": "RAUCH GARY M", "role": "VP - Finance, Treasurer", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 5250.0, "score": 34.6, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "4 insiders pile into AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006213/0001493152-15-006213-index.htm", "trade_date": "2015-12-11", "timestamp": "2015-12-11", "mins": 5730712}, {"id": "0001144204-14-052276", "src": "INSIDERS", "ticker": "AKER", "cik": "1321834", "company": "Q/C TECHNOLOGIES, INC.", "company_raw": "Akers Biosciences Inc", "who": "Gary M. Rauch", "who_key": "RAUCH GARY M", "role": "VP of Finance, Treasurer", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 3213.0, "score": 32.5, "price_sensitive": false, "cluster": 0, "industry": "In Vitro & In Vivo Diagnostic Substances", "country": "United States", "headline": "That makes 5 insiders into AKER", "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000114420414052276/0001144204-14-052276-index.htm", "trade_date": "2014-08-22", "timestamp": "2014-08-22", "mins": 6416152}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Hudson Bay Capital Management LP", "who_key": "Hudson Bay Capital Management LP", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 555550.43, "sold": 81368.78, "net": 474181.65, "trades": 3, "top_score": 52.7, "lean": "buying", "history": [{"action": "SELL", "amount": 1792.78, "date": "2020-02-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000097/0001393825-20-000097-index.htm"}, {"action": "SELL", "amount": 79576.0, "date": "2020-02-27", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000096/0001393825-20-000096-index.htm"}, {"action": "BUY", "amount": 555550.43, "date": "2019-12-20", "score": 52.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000002/0001393825-20-000002-index.htm"}], "latest": {"action": "SELL", "amount": 1792.78, "date": "2020-02-28", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000139382520000097/0001393825-20-000097-index.htm"}}, {"who": "Gary M. Rauch", "who_key": "RAUCH GARY M", "role": "VP - Finance, Treasurer", "person_type": "EXEC", "person_label": "Execs", "bought": 8463.0, "sold": 0, "net": 8463.0, "trades": 2, "top_score": 34.6, "lean": "buying", "history": [{"action": "BUY", "amount": 5250.0, "date": "2015-12-11", "score": 34.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006213/0001493152-15-006213-index.htm"}, {"action": "BUY", "amount": 3213.0, "date": "2014-08-22", "score": 32.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000114420414052276/0001144204-14-052276-index.htm"}], "latest": {"action": "BUY", "amount": 5250.0, "date": "2015-12-11", "score": 34.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315215006213/0001493152-15-006213-index.htm"}}, {"who": "John J. Gormally", "who_key": "Gormally John J", "role": "Chief Executive Officer", "person_type": "CEO", "person_label": "CEOs", "bought": 5566.86, "sold": 0, "net": 5566.86, "trades": 1, "top_score": 49.8, "lean": "buying", "history": [{"action": "BUY", "amount": 5566.86, "date": "2016-05-24", "score": 49.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216010274/0001493152-16-010274-index.htm"}], "latest": {"action": "BUY", "amount": 5566.86, "date": "2016-05-24", "score": 49.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216010274/0001493152-16-010274-index.htm"}}, {"who": "Raymond Francis Akers Jr", "who_key": "AKERS RAYMOND FRANCIS JR", "role": "Executive Chairman, Secretary, Director", "person_type": "EXEC", "person_label": "Execs", "bought": 2814.0, "sold": 0, "net": 2814.0, "trades": 1, "top_score": 22.4, "lean": "buying", "history": [{"action": "BUY", "amount": 2814.0, "date": "2016-01-05", "score": 22.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216006629/0001493152-16-006629-index.htm"}], "latest": {"action": "BUY", "amount": 2814.0, "date": "2016-01-05", "score": 22.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1321834/000149315216006629/0001493152-16-006629-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-02", "title": "Insider transaction", "accession": "0001493152-26-045586", "price_sensitive": false}, {"form": "4/A", "date": "2026-10-02", "title": "Form 4/A", "accession": "0001493152-26-045576", "price_sensitive": false}, {"form": "3", "date": "2026-09-22", "title": "Initial insider holdings", "accession": "0001493152-26-043729", "price_sensitive": false}, {"form": "8-K", "date": "2026-09-18", "title": "Material event", "accession": "0001493152-26-043401", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-11", "title": "Material event", "accession": "0001493152-26-042394", "price_sensitive": true}, {"form": "3", "date": "2026-08-17", "title": "Initial insider holdings", "accession": "0001493152-26-038855", "price_sensitive": false}, {"form": "10-Q", "date": "2026-08-12", "title": "Quarterly report", "accession": "0001493152-26-037333", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-02", "title": "Material event", "accession": "0001493152-26-031946", "price_sensitive": true}, {"form": "10-Q", "date": "2026-05-15", "title": "Quarterly report", "accession": "0001493152-26-023751", "price_sensitive": true}, {"form": "4", "date": "2026-05-14", "title": "Insider transaction", "accession": "0001493152-26-023217", "price_sensitive": false}, {"form": "10-K/A", "date": "2026-04-29", "title": "Form 10-K/A", "accession": "0001493152-26-019663", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016913", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016910", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016914", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016911", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016912", "price_sensitive": false}, {"form": "4", "date": "2026-04-15", "title": "Insider transaction", "accession": "0001493152-26-016909", "price_sensitive": false}, {"form": "10-K", "date": "2026-04-15", "title": "Annual report", "accession": "0001493152-26-016872", "price_sensitive": true}, {"form": "NT 10-K", "date": "2026-03-31", "title": "Form NT 10-K", "accession": "0001493152-26-014222", "price_sensitive": false}, {"form": "8-K", "date": "2026-03-13", "title": "Material event", "accession": "0001493152-26-010070", "price_sensitive": true}, {"form": "EFFECT", "date": "2026-02-17", "title": "Form EFFECT", "accession": "9999999995-26-000618", "price_sensitive": false}, {"form": "CORRESP", "date": "2026-02-12", "title": "Form CORRESP", "accession": "0001493152-26-006490", "price_sensitive": false}, {"form": "S-3", "date": "2026-02-11", "title": "Shelf registration", "accession": "0001493152-26-006234", "price_sensitive": false}, {"form": "4", "date": "2026-01-30", "title": "Insider transaction", "accession": "0001493152-26-004565", "price_sensitive": false}, {"form": "3", "date": "2026-01-30", "title": "Initial insider holdings", "accession": "0001493152-26-004564", "price_sensitive": false}], "performance": {"ticker": "AKER", "has_prices": false, "summary": null, "buys": [{"who": "Hudson Bay Capital Management LP", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 555550.43, "date": "2019-12-20", "score": 52.7, "ref_price": null, "return": null}, {"who": "Gormally John J", "person_type": "CEO", "person_label": "CEOs", "role": "Chief Executive Officer", "amount": 5566.86, "date": "2016-05-24", "score": 49.8, "ref_price": null, "return": null}, {"who": "AKERS RAYMOND FRANCIS JR", "person_type": "EXEC", "person_label": "Execs", "role": "Executive Chairman, Secretary, Director", "amount": 2814.0, "date": "2016-01-05", "score": 22.4, "ref_price": null, "return": null}, {"who": "RAUCH GARY M", "person_type": "EXEC", "person_label": "Execs", "role": "VP - Finance, Treasurer", "amount": 5250.0, "date": "2015-12-11", "score": 34.6, "ref_price": null, "return": null}, {"who": "RAUCH GARY M", "person_type": "EXEC", "person_label": "Execs", "role": "VP of Finance, Treasurer", "amount": 3213.0, "date": "2014-08-22", "score": 32.5, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}